On December 16, 2025, the European Commission published (COM(2025) 1023), a proposal to amend Regulation (EU) 2017/746 (IVDR).
Removal of 5-Year Certificate Expirations:
Current Regulation: Certificates of Conformity issued by Notified Bodies automatically expire after a maximum of 5 years.
Proposed Change: The 5-year maximum limit is removed. Certificates will no longer expire automatically; instead, Notified Bodies will perform risk-proportionate periodic reviews, reducing re-certification overhead for mature diagnostic platforms.
Flexibility for In-House Diagnostics:
Current Regulation: Health institutions can develop and use in-house IVDs only if no equivalent commercial alternative exists on the market.
Proposed Change: The strict "no commercial alternative" restriction would be removed, allowing hospitals and clinical labs to use and share in-house assays with other healthcare facilities under clearer conditions.
Streamlined Performance Evidence & Consultations Elimination of PECP:
The Performance Evaluation Consultation Procedure (PECP) for Class D (high-risk) IVDs is proposed to be removed to eliminate unnecessary procedural delays.
Expanded Evidence Acceptance:
Expands acceptable sources of clinical and performance evidence, allowing manufacturers to leverage historical data and existing scientific literature more effectively.
Small and Medium Enterprises PRRC Rules:
The requirement for a Person Responsible for Regulatory Compliance (PRRC) to be permanently and continuously available is relaxed for micro- and small enterprises to simply being "available" (e.g., via external consultants).
Proportional Auditing:
Introduces predictable fee schedules, remote audit options, reduced audit frequencies, and limits on unannounced audits by Notified Bodies.
Lower PSUR Frequency:
Periodic Safety Update Reports (PSURs) will no longer require annual resubmissions for all risk categories; filing frequencies will be reduced (e.g., every two years or "as necessary" depending on risk).
Support for Innovation & Digitalization Introduces structured "regulatory sandboxes" to allow real-world or simulated testing of breakthrough IVD technologies, adaptive software, and AI-driven diagnostics under regulatory supervision.
Digital & Cybersecurity Rules:
Modernizes requirements to explicitly address IVD software classifications, cybersecurity standards, and automated incident reporting.
Legislative Status:
These proposals are currently undergoing review by the European Parliament and Council, with final adoption anticipated by late 2026.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.